Mallinckrodt, LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Mallinckrodt, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013351
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging agents, global medical imaging, nuclear imaging and contrast media and devices. Its generic products include addiction treatment products, compounding powders, unit dose products, and resource tool kit, among others. Mallinckrodt’s specialty brands and generics segments commercializes in the areas of neurology, nephrology, rheumatology, ophthalmology, pulmonology, rare disease products, and others. The company offers treatment to health conditions including pain, central nervous system disorders, autoimmune and rare diseases. The company has its presence in the US, the UK and Ireland. Mallinckrodt is headquartered in St. Louis, Missouri, the US.

Mallinckrodt, LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mallinckrodt, LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mallinckrodt, LLC, Medical Devices Deals, 2011 to YTD 2017 9
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Mallinckrodt Completes Acquisition Of Rights To Roxicodone From Xanodyne Pharma 11
Venture Financing 12
CNS Therapeutics Secures An Additional US$0.05 Million In Venture Financing 12
Partnerships 13
Mallinckrodt Enters Into Co-Promotion Agreement With Horizon Pharma For Duexis 13
Zogenix Enters Into Co-Promotion Agreement With Mallinckrodt For Sumavel DosePro 15
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 16
Licensing Agreements 17
Intellipharmaceutics International Enters into Licensing Agreement with Mallinckrodt 17
Acquisition 18
Mallinckrodt Completes Acquisition Of CNS Therapeutics For US$100 Million 18
Mallinckrodt, LLC – Key Competitors 20
Mallinckrodt, LLC – Key Employees 21
Mallinckrodt, LLC – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Key Facts 2
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mallinckrodt, LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mallinckrodt, LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Mallinckrodt, LLC, Medical Devices Deals, 2011 to YTD 2017 9
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mallinckrodt Completes Acquisition Of Rights To Roxicodone From Xanodyne Pharma 11
CNS Therapeutics Secures An Additional US$0.05 Million In Venture Financing 12
Mallinckrodt Enters Into Co-Promotion Agreement With Horizon Pharma For Duexis 13
Zogenix Enters Into Co-Promotion Agreement With Mallinckrodt For Sumavel DosePro 15
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 16
Intellipharmaceutics International Enters into Licensing Agreement with Mallinckrodt 17
Mallinckrodt Completes Acquisition Of CNS Therapeutics For US$100 Million 18
Mallinckrodt, LLC, Key Competitors 20
Mallinckrodt, LLC, Key Employees 21
Mallinckrodt, LLC, Subsidiaries 22

★海外企業調査レポート[Mallinckrodt, LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CohBar Inc (COB.U):企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Herman Miller Inc (MLHR):企業の財務・戦略的SWOT分析
    Herman Miller Inc (MLHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Hong Kong and China Gas Company Limited:企業の戦略・SWOT・財務分析
    The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • NXP Semiconductors NV (NXPI):企業の財務・戦略的SWOT分析
    NXP Semiconductors NV (NXPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Plenus Company Limited:企業の戦略・SWOT・財務分析
    Plenus Company Limited - Strategy, SWOT and Corporate Finance Report Summary Plenus Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Immunogen, Inc.:企業の戦略・SWOT・財務分析
    Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Rockwell Automation Inc (ROK):石油・ガス:M&Aディール及び事業提携情報
    Summary Rockwell Automation Inc (Rockwell) is a provider of industrial automation power, control and information systems. The company offers connected components, midrange architecture system, asset and consultancy management; engineered packages and panels integration; front end engineering and des …
  • Gibson Energy Inc (GEI):企業の財務・戦略的SWOT分析
    Gibson Energy Inc (GEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Chronix Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Chronix Biomedical Inc (Chronix Biomedical) is a molecular diagnostic company that develops blood tests for monitoring minimal residual disease in cancer patients. The company offers tests such as second opinion tests and delta dot tests. Its second opinion tests include supplementary blood …
  • Liechtensteinische Landesbank AG:企業の戦略・SWOT・財務情報
    Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Emsland Group:企業の戦略・SWOT・財務分析
    Emsland Group - Strategy, SWOT and Corporate Finance Report Summary Emsland Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Heiwa Real Estate Co Ltd:企業の戦略・SWOT・財務情報
    Heiwa Real Estate Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Heiwa Real Estate Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alliance Data Systems Corp (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corp (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Almarai Company:企業の戦略・SWOT・財務情報
    Almarai Company - Strategy, SWOT and Corporate Finance Report Summary Almarai Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Medline Industries Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medline Industries Inc (Medline) is a manufacturer and distributor of healthcare supplies in the US. The company offers products under various categories, including Exam Gloves, Textiles, Durable Medical Equipment, Skin Care, OR Kits, Protective Apparel, Gauze, Packs and Gowns, Bathing Syste …
  • QIMR Berghofer Medical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary QIMR Berghofer Medical Research Institute (QIMR), formerly Queensland Institute of Medical Research is a medical research institute that offers education and research programs. The institute offers its research programs in the areas of mental health, cancer, infectious disease, and complex d …
  • Telekom Malaysia Bhd (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Bhd (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sarah Cannon Research Institute LLC-製薬・医療分野:企業M&A・提携分析
    Summary Sarah Cannon Research Institute LLC (SCRI) is a research institute that offers integrated cancer services. The institute conducts clinical research programs for advancing cancer therapies. Its services include blood cancer network, cancer care overview, cardiovascular research, contract rese …
  • Bajaj Allianz General Insurance Company Limited:企業の戦略・SWOT・財務情報
    Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Maxeda B.V.:企業の戦略・SWOT・財務情報
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆